Spindle Biotech Inc.
Spindle Biotech offers CRISPR gene-editing companies synthetic RNA at a lower cost in a more scalable manner without sacrificing accuracy.
- Stage Product In Market
- Industry Biotechnology
- Location Toronto, ON, Canada
- Currency USD
- Founded June 2017
- Employees 2
- Incorporation Type C-corp
- Website spindle.bio
Company Summary
Spindle Biotech offers unique solutions to companies performing CRISPR gene editing R&D experiments by providing synthetic RNA at a lower cost in a more scalable, time-efficient manner and without sacrificing accuracy versus the present industry standard. Eventually, we will provide our customers the means to do it all in-house with a reasonable R&D budget, something that today is not feasible for most of the customer base.
Team
-
CEO -
Dr. Brendan HusseyCSOSynthetic Biology
-
Mark WilburAdvisor/Chief Revenue Officer20+ years of experience life science & biopharma employed mainly in startups. Have participated in seed stage to M&A, and led exit strategy. I prefer strategy consulting opportunities and taking on a challenge.
https://www.linkedin.com/in/markwilbur/
Advisors
-
Professor Keith PardeeUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.